FDA Drug Application (021251) for KALETRA by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number021251
Product Number001
FormSOLUTION;ORAL
Dosage80MG/ML;20MG/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameKALETRA
Active IngredientLOPINAVIR; RITONAVIR

Active IngredientCount
List of drugs with Active Ingredient LOPINAVIR3
List of drugs with Active Ingredient RITONAVIR11


Back to FDA Applications sponsored by ABBVIE